ARTICLE | Company News
CHF deal for Scios, Medtronic
May 9, 2001 7:00 AM UTC
SCIO and MDT will use MDT's Chronicle Implantable Hemodynamic Monitor (IHM) and implantable infusion systems to study the hemodynamic effects of SCIO's Natrecor recombinant B-type natriuretic peptide....